论文信息 - 3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma - 字舞流文

3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma

V. Mazzaferro | S. Ricci | J. Llovet | S. Zeuzem | D. Voliotis | P. Hilgard | J. Raoul | M. Moscovici | M. Shan